Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-04-09
1986-02-04
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514554, 514578, 26050112, 260513N, A61K 31205, A61K 31185, A61K 3144
Patent
active
045686831
ABSTRACT:
A lipid metabolism improving drug or pharmaceutical composition contains pantetheine-S-sulfonic acid as an active ingredient. When an effective dose of pantetheine-S-sulfonic acid or a pharmaceutically active, non-toxic salt thereof is administered to an animal, such as a human, in pure form or composition form, the lipid concentration in the plasma is lowered, lipid peroxide concentration in the serum and liver is lowered, B-lipo protein-cholesterol concentration in serum is decreased and HDL-cholesterol concentration is increased.
REFERENCES:
Moiseenok, A., et al., Khim.-Farm. Zh., 1981, 15(6), 76-81.
Chemical Abstracts, 90:37873w (1979) [Kopelevich, V., et al., Khim.-Farm. Zh., 1978, 12(8), 72-6].
Katsumata Omanabu
Suga Tetsuya
Tashiro Tomoyasu
Schwartz Richard A.
Sogo Pharmaceutical Company Limited
LandOfFree
Lipid metabolism with pantetheine-S-sulfonic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipid metabolism with pantetheine-S-sulfonic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipid metabolism with pantetheine-S-sulfonic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2341134